Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (CTKB)

CUSIP: 23285D109

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
+2,714,567
SEC-reported price per share
$4.37
Number of holders
163
Value change
+$11,134,305
Number of buys
87
Number of sells
62
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
129,694,583

Security key

23285D109

Report period

Q1 2026

Institutions

163

Top holders

10

Ownership snapshot

Top reported holders of CTKB - Cytek Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Topline Capital Managemen...
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13F 13D/G 3/4/5 Lead comparable stake: 5.3% 13D/G row: Topline Capital Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Topline Capital Management, LLC leads the comparable SEC ownership view at 5.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Topline Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Topline Capital Management, LLC 5.3%
BROWN CAPITAL MANAGEMENT LLC 3.9%
Don M. Hardison 0.01%
BlackRock, Inc. 13%
VANGUARD GROUP INC 5.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Topline Capital Management, LLC
13F 13D/G
Company
5.3%
from 13D/G
$37,584,453
7,442,466 shares
31 Dec 2025
BROWN CAPITAL MANAGEMENT LLC
13D/G 13F
Company
3.9%
$17,204,316
4,958,016 shares
-$8,695,650 30 Sep 2025
Don M. Hardison
3/4/5
Director
0.01%
$152,819
15,706 shares
mixed-class rows
05 Jun 2025
BlackRock, Inc.
13F
Company
13F
13%
$86,723,792
17,173,028 shares
31 Dec 2025
VANGUARD GROUP INC
13F
Company
13F
5.8%
$37,751,160
7,475,477 shares
31 Dec 2025
HHLR ADVISORS, LTD.
13F
Company
13F
5.1%
$33,618,002
6,657,030 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
163
Shares
85,067,527
Rows available
163
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
155
Q1 2026 holders
163
Holder diff
8
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .